Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Endra Life Sciences Inc (NQ: NDRA ) 0.5091 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Endra Life Sciences Inc < Previous 1 2 3 Next > ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update August 22, 2024 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences Announces Reverse Stock Split August 16, 2024 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024 August 13, 2024 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences Announces Leadership Changes August 13, 2024 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14 August 07, 2024 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering June 04, 2024 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Provides Update Following In-person Meeting with FDA May 20, 2024 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update May 14, 2024 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024 May 07, 2024 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents May 02, 2024 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update March 28, 2024 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024 March 21, 2024 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences Installs First TAEUS System in the UK February 27, 2024 From ENDRA Life Sciences Inc. Via Business Wire New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS System February 21, 2024 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe February 14, 2024 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology November 29, 2023 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences to Participate in The Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference November 27, 2023 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update November 14, 2023 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents November 08, 2023 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023 November 07, 2023 From ENDRA Life Sciences Inc. Via Business Wire ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD’s The Liver Meeting® 2023 November 06, 2023 From ENDRA Life Sciences Inc. Via Business Wire Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023 September 07, 2023 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA August 30, 2023 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents August 23, 2023 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update August 14, 2023 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA August 14, 2023 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023 August 01, 2023 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences Announces Adjournment of 2023 Annual Meeting of Stockholders to July 25, 2023 July 06, 2023 From ENDRA Life Sciences Inc. Via Business Wire Study Highlighting ENDRA Life Sciences’ TAEUS Technology to be Presented at EASL International Liver Congress 2023 June 07, 2023 From ENDRA Life Sciences Inc. Via Business Wire ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update May 15, 2023 From ENDRA Life Sciences Inc. Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.